|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM317774646 |
| 003 |
DE-627 |
| 005 |
20250228095213.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1111/jfd.13305
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1059.xml
|
| 035 |
|
|
|a (DE-627)NLM317774646
|
| 035 |
|
|
|a (NLM)33210311
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a NaveenKumar, Singaiah
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Recombinant viral proteins delivered orally through inactivated bacterial cells induce protection in Macrobrachium rosenbergii (de Man) against White Tail Disease
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 26.05.2021
|
| 500 |
|
|
|a Date Revised 26.05.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a GENBANK: JQ418298, JQ418299
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2020 John Wiley & Sons Ltd.
|
| 520 |
|
|
|a White tail disease (WTD) is a disease of Macrobrachium rosenbergii caused by Macrobrachium rosenbergii nodavirus (MrNV) and extra small virus (XSV) with the potential to devastate the aquaculture industry. The present study aimed to explore the possible protection of M. rosenbergii against the disease by oral administration of bacterially expressed recombinant capsid proteins of MrNV and XSV. Juvenile M. rosenbergii were fed with the feed coated with inactivated bacteria encapsulated expressed recombinant viral proteins either individually or in combination for 7 days. Challenge studies using WTD causing agents were carried out after 3 (group I), 10 (group II) and 20 (group III) days post-feeding of viral proteins. Recombinant capsid protein of MrNV showed better protection when compared to other treatments with relative per cent survival of 62.5% (group I), 57.9% (group II) and 39.5% (group III). Treatment controls of groups I, II and III showed 100%, 95% and 95% mortality, respectively. The study demonstrates that oral administration of recombinant capsid proteins of MrNV and XSV provides effective protection against WTD in freshwater prawn
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a oral administration
|
| 650 |
|
4 |
|a protection
|
| 650 |
|
4 |
|a recombinant protein
|
| 650 |
|
4 |
|a white tail disease
|
| 650 |
|
7 |
|a Capsid Proteins
|2 NLM
|
| 650 |
|
7 |
|a Recombinant Proteins
|2 NLM
|
| 650 |
|
7 |
|a Vaccines, Inactivated
|2 NLM
|
| 650 |
|
7 |
|a Viral Vaccines
|2 NLM
|
| 700 |
1 |
|
|a Rai, Praveen
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Karunasagar, Indrani
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Karunasagar, Iddya
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of fish diseases
|d 1998
|g 44(2021), 5 vom: 01. Mai, Seite 601-612
|w (DE-627)NLM098166034
|x 1365-2761
|7 nnas
|
| 773 |
1 |
8 |
|g volume:44
|g year:2021
|g number:5
|g day:01
|g month:05
|g pages:601-612
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1111/jfd.13305
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 44
|j 2021
|e 5
|b 01
|c 05
|h 601-612
|